Metagenomi Therapeutics, Inc. Common Stock
MGX
Closed
$1.27
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Emeryville, California and currently employs 119 full-time employees. The company went IPO on 2024-02-09.
Key stats
Open
$1.26
Volume
190.95K
Market cap
$47.44M
Prev. close
$1.26
Impl / hst vl
-
Open interest
$0.00
$1.22
Day’s Range
$1.30
$1.13
52W Range
$1.86
Valuation
44
Valuation score
Fairly Valued
P/E
-
P/S
2.17
P/B
0.35
Current ratio
6.43
Debt / Equity
-0.18
ROE
-51.23%
Gross margin
-
Income growth
2.36%
FCF growth
-10.29
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$8.50
The top 4 analysts forecasts that 12-month price may increase by 569.29%, with a low of $7.07 and a high of $9.45
$7.07
Low
$8.50
Avg
$9.45
High
Current price
Earnings
Q1 ‘26 revenue
$1.25M
Q1 ‘26 net income
-$23.06M
Revenue
Net income
Previous EPS
-$0.61
Estimate EPS
-$0.58
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply